THROMBEXX 15MG/ML S.C. 3 AMP

The first indication for which a hirudin�lepirudin�has been approved is treatment of heparin-induced thrombocytopenia (HIT). Also the recently completed trials for use of lepirudin in unstable angina indicate a potentially new indication. This review describes pharmacology and clinical applications of lepirudin with an emphasis on HIT and unstable angina.